Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Lucas R Hoffman

9PUBLICATIONS

26CO-AUTHORS

Infant and child healthMedical mycologyBiological adaptationFood properties (incl. characteristics and health benefits)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (9)

Sort by Publication Date:

|Jan 08, 2026

Longitudinal dynamics of respiratory microbiome composition in infants after tracheostomy placement.

Rebecca Steuart, Samantha N Atkinson, Lucas R Hoffman

|Oct 31, 2025

Culture and Adaptation of Pseudomonas aeruginosa During Early Infection in Children With Cystic Fibrosis.

Sumitra D Mitra, Maulin Soneji, Christopher M R Axline

|Jun 20, 2025

Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in 6- to 11-Year-Olds with Cystic Fibrosis: An Observational Study.

Jessica E Pittman, Sarah Morgan, Morgan McCreary

|Mar 24, 2025

Sticky Staph: A New Story about Mucoidy and Cystic Fibrosis.

Daniel J Wolter, Lucas R Hoffman

|Mar 15, 2022

Clinical Outcomes of Antipseudomonal versus Other Antibiotics among Children with Cystic Fibrosis without <i>Pseudomonas aeruginosa</i>.

Jonathan D Cogen, Anna V Faino, Frankline Onchiri

|Aug 05, 2021

The role of Psl in the failure to eradicate Pseudomonas aeruginosa biofilms in children with cystic fibrosis.

Amanda J Morris, Lindsay Jackson, Yvonne Cw Yau

Pageof 2

Frequent Collaborators

1 joint publications

Kevin S Mears

1 joint publications

Naseer Sangwan

1 joint publications

Piper M Treuting

1 joint publications

Nicholas Tolley

1 joint publications

Charles W Frevert

1 joint publications

Adeline M Hajjar

1 joint publications

Dustin R Long

1 joint publications

Daniel J Wolter

1 joint publications

Mimi Precit

1 joint publications

Kathryn McLean

Frequent Collaborators

1 joint publications

Kevin S Mears

1 joint publications

Naseer Sangwan

1 joint publications

Piper M Treuting

1 joint publications

Nicholas Tolley

Top Related Videos

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of <em>In Vivo</em> Upper Airway Immune-mediator Levels

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of <em>In Vivo</em> Upper Airway Immune-mediator Levels

Published on : Aug 07, 2017

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against <em>Pseudomonas aeruginosa</em> in Conditions More Relevant to the Cystic Fibrosis Lung

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against <em>Pseudomonas aeruginosa</em> in Conditions More Relevant to the Cystic Fibrosis Lung

Published on : Jun 05, 2012

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Published on : Oct 15, 2017

See more related videos

Top Related Videos

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of <em>In Vivo</em> Upper Airway Immune-mediator Levels

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of <em>In Vivo</em> Upper Airway Immune-mediator Levels

Published on : Aug 07, 2017

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against <em>Pseudomonas aeruginosa</em> in Conditions More Relevant to the Cystic Fibrosis Lung

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against <em>Pseudomonas aeruginosa</em> in Conditions More Relevant to the Cystic Fibrosis Lung

Published on : Jun 05, 2012

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Published on : Oct 15, 2017

See more related videos